Results 101 to 110 of about 644,370 (183)

An integrated computational, in vitro and metabolomics approach to the discovery of novel aromatase inhibitors with anti-breast cancer activities. [PDF]

Sci Rep
Maiuthed A, Chatwichien J, Sandech N, Yang MC, Krobthong S, Rukthong P, Svasti J, Ruchirawat S, Eurtivong C.   +8 more
europepmc   +1 more source

Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer. [PDF]

Discov Oncol
Najafizade N, Zarei S, Elhaie M, Roayaei M.   +3 more
europepmc   +1 more source

Aromatase Inhibitors

Oncology Times, 2008
openaire   +3 more sources

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management. [PDF]

Cancers (Basel)
Nardin S, Ruffilli B, Landolfo TL, Isingrini G, Taglialatela I, Delbarba A, D'Avanzo F, Rossi V, Celentano E, Conte B, Nardin M, Gennari A.   +11 more
europepmc   +1 more source

The Combination of Aromatase Inhibitors and GH Treatment for Idiopathic Short Stature in Male Adolescents. [PDF]

J Clin Endocrinol Metab
Cui Y, Zhang Q, Hou L, Luo X.
europepmc   +1 more source

A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors. [PDF]

Psychol Conscious (Wash D C)
Montgomery GH, Schnur JB, Tiersten A, Benck K, Erblich J.   +4 more
europepmc   +1 more source

Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report. [PDF]

Cureus
Gayford K, O'Neill N, Hadeya A, Ottaviani D.   +3 more
europepmc   +1 more source

Aromatase Inhibitor [PDF]

, 2020
openaire   +1 more source

Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling. [PDF]

BMC Cancer
Ojedele OA, Hamdi N, Mughram MHA, Alyami EM, Dauelbait M, Almohammed OA.   +5 more
europepmc   +1 more source

Comparative effectiveness of bone-protective interventions for aromatase inhibitors-induced bone loss in postmenopausal women with early breast cancer: a network meta-analysis. [PDF]

Front Oncol
Xu Y, Lai J, Mai M, Tang Y, Wu Z.
europepmc   +1 more source